NEURONES : + 8,6% de croissance organique au 1er trimestre 2024
May 15, 2024 11:40 ET
|
NEURONES
INFORMATION PRESSERubrique : C.A. 1er trimestre 2024 Nanterre, le 15 mai 2024 (après Bourse) + 8,6% de croissance organique au 1er trimestre 2024 (en millions d’euros)T1 2023T1...
NEURONES: organic growth up 8.6% in 1st quarter 2024
May 15, 2024 11:40 ET
|
NEURONES
PRESS INFORMATIONHeading: 1st quarter 2024 revenues Nanterre, May 15, 2024 (after trading) Organic growth up 8.6% in 1st quarter 2024 (in millions of euros)Q1 2023Q1 2024Growthof which...
Wreaths Across America and the Military Order of the World Wars Forge Partnership to Honor Veterans
April 02, 2024 09:00 ET
|
Wreaths Across America
COLUMBIA FALLS, Me., and ALEXANDRIA, Va., April 02, 2024 (GLOBE NEWSWIRE) -- Wreaths Across America (WAA) proudly announces the signing of a Memorandum of Understanding (MOU) with the Military Order...
NMDP Cycle Kicks Off Nationwide Cycling Events Giving Hope to Patients in Need of a Blood Stem Cell Transplant
March 29, 2024 11:19 ET
|
NMDP
MINNEAPOLIS, March 29, 2024 (GLOBE NEWSWIRE) -- NMDPSM Cycle (formerly Be The Match® Tour de TC) kicks off March 30 on a six-ride tour throughout the country to raise funds to help remove barriers...
EAGLE PHARMACEUTICALS 48 HOUR DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
February 08, 2024 11:00 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
EAGLE PHARMACEUTICALS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
February 01, 2024 17:30 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
January 24, 2024 09:45 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
January 10, 2024 10:00 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2024
December 20, 2023 16:04 ET
|
Micron Technology, Inc.
BOISE, Idaho, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its first quarter of fiscal 2024, which ended November 30, 2023. Fiscal Q1 2024...
Eagle Pharmaceuticals Investor Update: Kaplan Fox & Kilsheimer LLP Notifies Eagle Pharmaceuticals Investors of a Class Action and Upcoming Deadline
December 13, 2023 12:30 ET
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox notifies investors of Class Action filed against Eagle Pharmaceuticals.